Group 1 - The company has established a joint investment with AglaeaPharma to set up Guangxi Aglaea, focusing on multi-target small molecule compound drug screening and early disease detection and diagnostic technology development [2] - AglaeaPharma's project platform has developed multiple technology platforms, product pipelines, and a series of products, forming a globally integrated innovative research and development system [2] - The company will continue to monitor the project's progress and fulfill its information disclosure obligations in a timely manner [2]